Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

FMED vs XDAT: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, FMED returned +27.4% to XDAT's −11.5%; 0% of their weight is in the same names.

askIQ about this page

askIQ about FMED and XDAT

Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $3.7m on Nov 3, 2026 for Franklin Exponential Data ETF.

At a glance
21.8%
FMED in the S&P 500
60.4%
XDAT in the S&P 500
+27.4%
FMED total return, 1 year
−11.5%
XDAT total return, 1 year
FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500
78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 33% of the fund · 72 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in78% of its weight is outside the S&P 50022% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.22%78%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

XDAT · 1 year to Nov 4, 2026 40% of its weight is outside the S&P 500
40% of its weight is outside the S&P 50060% of XDAT's weight is in S&P 500 companies and 40% is outside the index. Holdings as of Jun 30, 2026.60%40%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 86% · top ten 56% of the fund · 59 holdings as filed for Jun 30, 2026 · Nasdaq-100: 52% in40% of its weight is outside the S&P 50060% of XDAT's weight is in S&P 500 companies and 40% is outside the index. Holdings as of Jun 30, 2026.60%40%in the S&P 500outsideactive share 86% · Nasdaq-100: 52% in

60% of XDAT's weight is in S&P 500 companies and 40% is outside the index. Holdings as of Jun 30, 2026.

Pair scorecard

Both cost 0.50% a year; their one-year returns differ by 38.9 points.

Points (pts) are percentage points.

FMED vs XDAT: Holdings Overlap & Returns
MeasureFMEDXDAT
Return
Total return, 1 year+27.4%−11.5%
Drawdown
Below its all-time high21.1%, high on Nov 9, 2021
Against its benchmark
What it tracksBroad innovation and megatrendsBroad innovation and megatrends
Its benchmark, total return, 1 year+14.8%
Against its benchmark, 1 yearbehind by 26.3 pts
Cost and size
Expense ratio0.50%0.50%
Net assets, FMED as of Sep 30, 2026 and XDAT as of Nov 3, 2026$52m$3.7m
Holdings
Holdings in common0%

Method

What they share

0%

By the books each fund has filed, FMED and XDAT hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Aug 31, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first FMED XDAT
Only in one fund ↓
Only in FMED
10X GENOMICS INC 5.19%
THERMO FISHER SCIENTIFIC INC 3.83%
DANAHER CORP 3.73%
NATERA INC 3.30%
ARGENX SE 3.20%
LIFESTANCE HEALTH GROUP INC 3.00%
REVOLUTION MEDICINES INC 2.87%
ILLUMINA INC 2.82%
Only in XDAT
CLOUDFLARE INC 10.04%
ALPHABET INC 9.66%
META PLATFORMS INC 6.36%
SNOWFLAKE INC 4.97%
APPLOVIN CORP 4.97%
PALO ALTO NETWORKS INC 4.49%
CROWDSTRIKE HOLDINGS INC 4.34%
DATADOG INC 4.07%
Check overlap with more funds →

Window by window

Window by window: FMED vs XDAT: Holdings Overlap & Returns
Total returnvs its benchmark
WindowFMEDXDATFMEDXDAT
3 months+14.9%−7.7%not measured−7.4 pts vs IWV
6 months+31.2%+2.1%not measured−2.8 pts vs IWV
1 year+27.4%−11.5%not measured−26.3 pts vs IWV
3 years+57.8%+33.3%not measured−47.7 pts vs IWV
Since launchNot the same days: FMED Jun 2023 · XDAT Jan 2021+31.7%−1.8%not measured−106.1 pts vs IWV

Open this comparison in the app →

Side by side

FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies XDAT Franklin Exponential Data ETF · Holds 59 stocks in broad innovation and megatrends, 60% of its weight in S&P 500 companies
Theme Broad innovation and megatrends Broad innovation and megatrends
In the S&P 500 21.8% 60.4%
Active share vs the S&P 500 97.5% 86.2%
In the Nasdaq-100 5.1% 52.2%
Holdings 72 59
Top ten, share of the fund 33.2% 56.1%
Expense ratio 0.50% 0.50%
Fee for the differing part 0.51% 0.58%
Total return, 1 year +27.4% −11.5%
vs its benchmark not measured −26.3 pts vs IWV
Below its high −0.9% −21.1%
Net assets, FMED as of Sep 30, 2026 and XDAT as of Nov 3, 2026 $52m $3.7m

As of Nov 4, 2026. Source: ETFIQ.

0% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

XDAT

Over the year to Nov 4, 2026 the fund returned −11.5% with distributions reinvested against +14.8% for its benchmark, the Russell 3000 Index, so a holder was behind by 26.3 pts.

By weight, 60% of XDAT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 86%. The top ten holdings are 56% of the fund across 59 positions, as filed for Jun 30, 2026. It sits 21.1% below its all-time high of Nov 9, 2021.

Questions people ask

Do FMED and XDAT hold the same stocks?
By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FMED or XDAT?
FMED has 22% of its weight in S&P 500 names and XDAT has 60%, so FMED differs more from the index.
Which is cheaper, FMED or XDAT?
FMED and XDAT both charge 0.50% a year, so neither is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, FMED against XDAT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-xdat

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.